摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-nitro-5-methylthiobenzoic acid

中文名称
——
中文别名
——
英文名称
2-nitro-5-methylthiobenzoic acid
英文别名
5-methyl-2-nitrobenzenecarbothioic S-acid
2-nitro-5-methylthiobenzoic acid化学式
CAS
——
化学式
C8H7NO3S
mdl
——
分子量
197.214
InChiKey
HNFBHYFCPBLLQY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    63.9
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    重氮甲烷2-nitro-5-methylthiobenzoic acid甲醇 为溶剂, 生成 methyl 2-nitro-5-methylthiobenzoate
    参考文献:
    名称:
    Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of
    摘要:
    本文描述了具有以下结构的吡啶并[2,1-b]喹唑啉的化学式##STR1##其中R.sub.1、R.sub.1'、R.sub.2、R.sub.2'、R.sub.3、R.sub.3'、R.sub.4和R.sub.10如下所述,以及其制备方法。化合物I和II的化学式对于预防过敏反应是有用的。
    公开号:
    US04348396A1
  • 作为产物:
    描述:
    参考文献:
    名称:
    Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of
    摘要:
    本文描述了具有以下结构的吡啶并[2,1-b]喹唑啉的化学式##STR1##其中R.sub.1、R.sub.1'、R.sub.2、R.sub.2'、R.sub.3、R.sub.3'、R.sub.4和R.sub.10如下所述,以及其制备方法。化合物I和II的化学式对于预防过敏反应是有用的。
    公开号:
    US04348396A1
点击查看最新优质反应信息

文献信息

  • Immunoassay for specific determination of S-adenosylmethionine and analogs thereof in biological samples
    申请人:Chang Chiu Chin
    公开号:US20090263879A1
    公开(公告)日:2009-10-22
    This invention pertains to a method for detecting a compound in the presence of other compounds that are substantially similar in structure and metabolically related to the analyte. The invention is particularly suited for the detection of S-adenosylmethionine in the presence of S-adenosylhomocysteine, other nucleosides and derivatives in a biological sample. The methods of this invention involve an antibody produced specifically against S-adenosylmethionine; particularly, analogs modified strategically at the sulfonium position. An assay protocol comprises chemically modified analyte analog linked to an enzymatic reporter and the aforementioned antibody was used to demonstrate the assay specificity and sensitivity. Additional assay method with immobilized immunogen, the specific antibody, and an enzyme labeled secondary antibody was also described for illustration. The invention also features hapten design and novel compounds used as haptens to prepare immunogen and for the specific antibody production.
    本发明涉及一种在存在结构上与待分析物相似且代谢相关的其他化合物的情况下检测化合物的方法。本发明特别适用于在生物样品中检测S-腺苷甲硫氨酸,尤其是在存在S-腺苷同型半胱氨酸、其他核苷和衍生物的情况下。本发明的方法涉及针对S-腺苷甲硫氨酸特异性产生的抗体,特别是在硫杂环丙烷位点上进行战略性修饰的类似物。检测方案包括化学修饰的待分析物类似物与酶标记的报告物链接,并使用上述抗体来证明检测的特异性和灵敏度。此外,还描述了一种具有固定的免疫原、特异性抗体和酶标记的二级抗体的附加检测方法,以进行说明。本发明还具有半抗原设计和用作半抗原制备免疫原和特异性抗体生产的新化合物。
  • ASSAYS AND METHODS FOR SELECTING A TREATMENT REGIMEN FOR A SUBJECT WITH DEPRESSION
    申请人:PAMLAB, L.L.C.
    公开号:US20130267523A1
    公开(公告)日:2013-10-10
    Disclosed herein are novel assays, systems and kits for selecting a treatment regimen for a subject with depression by identifying at least one nucleic acid polymorphism, e.g., but not limited to, at the MTHFR, MTR, or MTRR locus, and/or determining expression levels of peripheral biomarkers (e.g., SAM, SAH, 4-HNE, and/or hsCRP) in a test sample from a human subject. These biomarkers can be used to determine the effectiveness of treating a depressed subject with a folate-containing compound (alone or as an adjunct to an antidepressant). Additionally, these biomarkers can be used to select an appropriate treatment regimen for subjects with treatment-resistant depression (e.g., resistant to at least one selective serotonin reuptake inhibitor). Methods and compositions for treating at least one symptom (e.g., at least one core symptom) of depression in a subject and/or determining or improving the effectiveness of an antidepressant drug taken by a subject are also provided herein.
  • US4348396A
    申请人:——
    公开号:US4348396A
    公开(公告)日:1982-09-07
  • US8344115B2
    申请人:——
    公开号:US8344115B2
    公开(公告)日:2013-01-01
  • US9546401B2
    申请人:——
    公开号:US9546401B2
    公开(公告)日:2017-01-17
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐